Trending

The Turtle Beach Victrix Pro BFG Reloaded Wireless Modular Controller is the real deal AI-guided ultrasound improves blood-brain barrier opening procedures by predicting bubble collapse Intel Foundry Details Process Milestones and Future Innovation at VLSI Symposium ADMA Biologics, Inc. (ADMA) Investors: August 10, 2026, Deadline in Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP Predictions Betting Explained: What is it, How Does it Work and Pros & Cons Anthropic "pauses" token-based billing for its Claude Agent SDK Mental health watchdog: We're 'losing ground' for most vulnerable Boy dies after cycling into parked lorry in Co Waterford Teaching Council inquiry into Enoch Burke allegations to be postponed EV-maker Rivian cuts hundreds of jobs after launching new SUV SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares Oil prices fall below US$80 per barrel Bringing visual security to apartment living with Ring Intercom Koa Smith Jetted to Indonesia to Score Barrels at This Secret Slab Nintendo Giving Away a Free Month of Switch Online in New Promotion The Turtle Beach Victrix Pro BFG Reloaded Wireless Modular Controller is the real deal AI-guided ultrasound improves blood-brain barrier opening procedures by predicting bubble collapse Intel Foundry Details Process Milestones and Future Innovation at VLSI Symposium ADMA Biologics, Inc. (ADMA) Investors: August 10, 2026, Deadline in Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP Predictions Betting Explained: What is it, How Does it Work and Pros & Cons Anthropic "pauses" token-based billing for its Claude Agent SDK Mental health watchdog: We're 'losing ground' for most vulnerable Boy dies after cycling into parked lorry in Co Waterford Teaching Council inquiry into Enoch Burke allegations to be postponed EV-maker Rivian cuts hundreds of jobs after launching new SUV SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares Oil prices fall below US$80 per barrel Bringing visual security to apartment living with Ring Intercom Koa Smith Jetted to Indonesia to Score Barrels at This Secret Slab Nintendo Giving Away a Free Month of Switch Online in New Promotion

ADMA Biologics, Inc. (ADMA) Investors: August 10, 2026, Deadline in Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP

Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class ac......

News Desk

Staff Writer

Published

Jun 17, 2026

Source

Business Wire

Analytics

0 0 0

ADMA Biologics, Inc. (ADMA) Investors: August 10, 2026, Deadline in Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP

AI Insight:Investors in ADMA Biologics, Inc. have a limited time to join a class action lawsuit against the company.

Kessler Topaz Meltzer & Check, LLP, a nationally recognized securities litigation law firm, has informed investors that a securities fraud class action lawsuit has been filed against ADMA Biologics, Inc. (ADMA) on behalf of investors who purchased the company's securities between August 9, 2021, and August 8, 2022. The lawsuit alleges that ADMA made false and misleading statements regarding its business and financial prospects, including its revenue growth and product development. As a result, investors who purchased ADMA securities during this time period may be eligible to recover their losses. The deadline to join the lawsuit is August 10, 2026, and investors are encouraged to contact Kessler Topaz Meltzer & Check, LLP to learn more about their potential rights and options.